Proposed cut-off CA19-9 values for detection of pancreatic cancer in patients with poorly glycemic controlled diabetes: a real-world study

Proposed cut-off CA19-9 values for detection of pancreatic cancer in patients with poorly glycemic controlled diabetes: a real-world study - Proposed cut-off CA19-9 values for detection of pancreatic cancer in patients with poorly glycemic controlled diabetes: a real-world study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049985

Enrollment

1000

Registered

2023-01-07

Start date

2021-04-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diabetes mellitus, pancreatic cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Inpatients with diabetes mellitus Patients with measured CA19-9 level Patients who have undergone abdominal echocardiography or abdominal CT Patients who could be evaluated for pancreatic cancer by examining abdominal symptoms and jaundice in six months after hospitalization

Exclusion criteria

Exclusion criteria: Patients who refuse participating in research in response to opt-out notification Patients with malignant tumors requiring treatment currently

Design outcomes

Primary

Measure	Time frame
Differences in CA19-9 values between patients with and without pancreatic cancer among patients with poorly glycemic controlled diabetes	—

Secondary

Measure	Time frame
Cut-off CA19-9 values for detection of pancreatic cancer in poorly glycemic controlled patients with diabetes, and its sensitivity and specificity	—

Countries

Japan

Contacts

Public ContactTaku Yamada

Saiseikai Yokohamashi Nanbu Hospital Diabetes and Endocrinology

hyyoh16y@yahoo.co.jp0458321111

Outcome results